Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05092178
Other study ID # exercise01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 6, 2019
Est. completion date November 20, 2022

Study information

Verified date December 2022
Source The First People's Hospital of Jingzhou
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Calorie-restricted(CR) diet and exercise were effective to reduce Metabolic syndrome(MetS), however, its effect on knee functions for MetS patients with degenerate meniscus lesions(DMLs) was still poorly investigated.


Description:

The CR diet and exercise group received a balanced diet with an energy consists carbohydrates 45-65%; fat 20-35%; and protein 10- 35% and a deficit of 600 kcal/day from their daily energy requirement. Total daily energy intake of 1200-2000 kcal/day were based on baseline weight, and for safety, no woman was provided with less than 1100 kcals/d and no man less than 1300 kcals/d. The energy of the intake calorie restricted diet per day was calculated based on the detailed composition of meals, such as rice, vegetables, eggs, pork, and beef, using the Chinese food composition tables. Our diets were cooked with traditional Chinese cooking methods such as boiling, stir-frying, and stewing. During the intervention, other lipid-lowering drugs were not allowed to intake supplement as it alters the outcome. Participants receive education or counseling by a dietitian for modulations of their caloric intake weekly. The exercise intervention included aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 d/week for 6 months. The aerobic exercises included walking on a treadmill, stationary cycling for at least 30 minutes for≥2 d/week. Resistance exercises included nine upper-extremity and lower-extremity exercise with weighting lift machines for ≥2 d/week, while, flexibility exercise including the major muscle-tendon groups (a total of 60 s per exercise) for ≥2 d/week. Participants performed 1 or 2 sets with 8-12 repetitions of each exercise. The exercise sessions were monitored by telephone video. Patients who complete at least 80% of diet restriction and exercise were included in analysis. Calorie restricted diet and exercise group contain both the above intervention.


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date November 20, 2022
Est. primary completion date November 4, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria: - • Must be age between 35 and 70 years old; - Clinical diagnosis of metabolic syndrome; Exclusion Criteria: - • Must be able to have no acute knee injury such as car crash or acute sports injury; - Must be able to have no knee surgeries history; - Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity; - Must be able to have no contraindications to MRI; - Must be able to have no severe cardiopulmonary disease; - Must be able to have no musculoskeletal or neuromuscular impairments ; - Must be able to have good visual, hearing, or cognitive;

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
calorie restricted diet and exercise
The CR diet and exercise group received a balanced diet with an energy consists carbohydrates 45-65%; fat 20-35%; and protein 10- 35% and a deficit of 600 kcal/day from their daily energy requirement.The exercise intervention consists of aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for=2 d•wk for six months. The aerobic exercises included walking on a treadmill, stationary cycling for at least 30 minutes for=2 d•wk, while, resistance exercises included nine upper-extremity and lower-extremity exercise with weighting lift machines for =2 d•wk, while, flexibility exercise including the major muscle-tendon groups (a total of 60 s per exercise) for =2 d•wk. Participants performed 1 or 2 sets with 8-12 repetitions of each exercise. The exercise sessions were monitored by telephone video.
exercise alone
In exercise alone group, participants then underwent their usual habitual dietary diet and the above exercise intervention during the program.

Locations

Country Name City State
China First Affiliated Hospital of Jinzhou Medical University Jinzhou Liaoning

Sponsors (1)

Lead Sponsor Collaborator
The First People's Hospital of Jingzhou

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Knee injury and Osteoarthritis Outcome Score (KOOS) score change The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems) Change from Baseline KOOS at 6 months
Primary The International Knee Documentation Committee Subjective Knee Evaluation score change The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.) The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst. Change from Baseline IKDC at 6 months
Primary The Knee injury and Osteoarthritis Outcome Score (KOOS) score change The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems) Change from Baseline KOOS at 12 months
Primary The International Knee Documentation Committee Subjective Knee Evaluation score change The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.) The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst. Change from Baseline IKDC at 12 months
Secondary subscales of KOOS pain score change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline pain at 6 months
Secondary subscales of KOOS pain score change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline pain at 12 months
Secondary subscales of KOOS symptoms score change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline symptoms at 6 months
Secondary subscales of KOOS symptoms score change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline symptoms at 12 months
Secondary KOOS activity of daily living change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline activity of daily living at 6 months
Secondary KOOS activity of daily living change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline activity of daily living at 12 months
Secondary sport and recreational function change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline sport and recreational function at 6 months
Secondary sport and recreational function change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline sport and recreational function at 12 months
Secondary knee related quality of life change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline knee related quality of life at 6 months
Secondary knee related quality of life change Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life. The minimum is 0 points, the maximum is 4 points. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula. Change from Baseline knee related quality of life at 12 months
Secondary systolic blood pressure change systolic blood pressure /mmHg Change from Baseline systolic blood pressure at 6 months
Secondary systolic blood pressure change systolic blood pressure /mmHg Change from Baseline systolic blood pressure at 12 months
Secondary diastolic blood pressure change diastolic blood pressure/mmHg Change from Baseline diastolic blood pressure at 6 months
Secondary diastolic blood pressure change diastolic blood pressure/mmHg Change from Baseline diastolic blood pressure at 12 months
Secondary body mass index change body mass index /kg/? Change from Baseline body mass index at 6 months
Secondary body mass index change body mass index /kg/? Change from Baseline body mass index at 12 months
Secondary weight change Weight-kg Change from Baseline weight at 6 months
Secondary weight change Weight-kg Change from Baseline weight at 12 months
Secondary high-density lipoprotein cholesterol change high-density lipoprotein cholesterol (mmol/L) Change from Baseline high-density lipoprotein cholesterol at 6 months
Secondary high-density lipoprotein cholesterol change high-density lipoprotein cholesterol (mmol/L) Change from Baseline high-density lipoprotein cholesterol at 12 months
Secondary low-density lipoprotein cholesterol change low-density lipoprotein cholesterol (mmol/L) Change from Baseline low-density lipoprotein cholesterol at 6 months
Secondary low-density lipoprotein cholesterol change low-density lipoprotein cholesterol (mmol/L) Change from Baseline low-density lipoprotein cholesterol at 12 months
Secondary triglycerides change triglycerides (mmol/l) Change from Baseline triglycerides at 6 months
Secondary triglycerides change triglycerides (mmol/l) Change from Baseline triglycerides at 12 months
Secondary total cholesterol change total cholesterol (mmol/L) Change from Baseline total cholesterol at 6 months
Secondary total cholesterol change total cholesterol (mmol/L) Change from Baseline total cholesterol at 12 months
Secondary fast blood glucose change fast blood glucose (mmol/L) Change from Baseline fast blood glucose at 6 months
Secondary fast blood glucose change fast blood glucose (mmol/L) Change from Baseline fast blood glucose at 12 months
Secondary waist circumstance change waist circumstance (cm) Change from Baseline waist circumstance at 6 months
Secondary waist circumstance change waist circumstance (cm) Change from Baseline waist circumstance at 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A